ReviewFrontiers in immunology2019

Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?

David P Funda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.